Veterans

BlossomHill Therapeutics Announces Upcoming Poster Presentation on Phase 1/2 SOLARA Trial of BH-30643, a First-in-class, Macrocyclic OMNI-EGFR™ Inhibitor, at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Altior Healthcare’s CFO, Jonathan Monroe, Recognized by the Los Angeles Business Journal for Turnaround Achievement

The recognition highlights Altior Healthcare's strong financial leadership and commitment to sustainable, patient-centered growth. LOS ANGELES, CA / ACCESS Newswire...

U.S. Food and Drug Administration Awards Year Two Proceeds from Orphan Products Grant Supporting Palvella Therapeutics’ Phase 3 SELVA Trial of QTORIN™ Rapamycin for Microcystic Lymphatic Malformations

DiMe and Google, alongside 30+ leading partners, launch “The Playbook: Implementing AI in Healthcare,” the first practical roadmap for AI adoption and scale in U.S. care delivery

WASHINGTON, Oct. 9, 2025 /PRNewswire/ -- The Digital Medicine Society (DiMe) announced the launch of The Playbook: Implementing AI in...

Theranica Brings First-in-Class, Drug-Free Migraine Care to the Forefront at CNS 2025 with Product Theater and New Real-World Evidence

With a dedicated product theater and new real-world evidence posters, Theranica will spotlight how the Nerivio® REN wearable is reshaping...

QuantiPath Appoints Jeff Nauseda as Director of Market Development — Bolstering Beef & Pet Food Reach Ahead of GenoPATHX Launch

DENVER, Oct. 7, 2025 /PRNewswire/ -- QuantiPath (quantipath.bio), the biotechnology company advancing genomic pathogen diagnostics for food safety, today announced the...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference

WILMINGTON, Del., Oct. 06, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", or the "Company"), a clinical-stage...

Medicare Holds, But the Rest of Healthcare Wobbles: Shutdown Threatens Trials, Telehealth and Safety Nets

Black Book Launches Rapid-Response Polls Tracking Real-Time Impacts on Providers, Payers and Patients WASHINGTON, D.C. / ACCESS Newswire / October...

error: Content is protected !!